Texas Instruments Inc. is reporting that Italian firm Esaote S.p.A. is using Texas Instruments’ digital signal processing (DSP) technology to power a range of innovative imaging instruments, from new ultrasounds to open MRI.
One of the technologies powered by the DSPs to attract our attention is called XStrain™. Installed on Esaote’s new MyLab™ XVision series ultrasound system, this diagnostic modality is described as “advanced cardiac technique for myocardial function evaluation.”
Here’s more from the company’s website:
XStrain™ is Esaote’s truly innovative new imaging method to estimate and quantify endocardial velocities of contraction and relaxation, and estimate and quantify local deformation of the heart, the Strain-Strain Rate top analysis technique for myocardial function evaluation.
XStrain is a non-invasive tool to better investigate the myocardial function and explore and quantify aspects of the heart’s physiology which were not possible to detect and quantify with previous ultrasound technologies.
Myocardial velocities and myocardial strain and strain rate can detect early impairment of myocardial contractility far before an impairment of the pump function (assessed as ejection fraction or stroke volume).
As it relies on angle-independent technology, XStrain allows for the assessment of the contractibility of both left and right ventricles.
XStrain advanced technology means:
eXtensive potential applications Innovation and non-invasiveness Angle-independent technology User-friendly interface Comprehensive measurement possibilities Intuitive workflow
XStrain advanced technology means:XStrain™ technology page…
Esaote website…
Texas Instruments press release…
